The global nephrostomy devices market size is anticipated to reach USD 2.32 billion by 2030 registering a CAGR of 7.9% from 2024 to 2030. Increasing awareness about nephrostomy devices among physicians and rising cases of kidney stone disease are driving the market. Increasing prevalence of ovarian, bladder, and prostate cancers and improving healthcare infrastructure in the developing economies are also among the key factors fueling the market growth.
North America is expected to register the highest market share owing to increasing prevalence of kidney stone disorder and ovarian, bladder, and prostate cancers. For instance, according to the American Cancer Society, around 22,240 new cases of ovarian cancer were diagnosed in 2018 in U.S. Major companies in this market are emphasizing on new product launches and innovations in the existing products. For instance, in February 2017, Cook Medical introduced Universa along with the two sets of percutaneous urinary drainage.
This product will be delivered within 1-3 business days.
North America is expected to register the highest market share owing to increasing prevalence of kidney stone disorder and ovarian, bladder, and prostate cancers. For instance, according to the American Cancer Society, around 22,240 new cases of ovarian cancer were diagnosed in 2018 in U.S. Major companies in this market are emphasizing on new product launches and innovations in the existing products. For instance, in February 2017, Cook Medical introduced Universa along with the two sets of percutaneous urinary drainage.
Nephrostomy Devices Market Report Highlights
- Guidewires dominated the market and accounted for a market share of 28.7% in 2023. It can be attributed to the rising geriatric population, improved hospital infrastructure, and technological advancements.
- Nephrostomy catheters are expected to grow at a significant CAGR over the forecast period. It can be attributed to the rising cases of kidney stones & urinary tract infections in both men and women.
- Hospitals dominated the market and accounted for a market share of 69.3% in 2023. Hospitals typically have access to the latest innovations in nephrostomy technology.
- North America nephrostomy devices market dominated in 2023. It can be attributed to the increasing prevalence of chronic kidney diseases in the region.
The leading players in the Nephrostomy Devices market include:
- Boston Scientific Corporation
- Teleflex Incorporated.
- Cardinal Health.
- BD
- Cook Medical
- B. Braun Melsungen AG
- Coloplast Group
- Olympus Corporation
- Argon Medical Devices.
- UreSil LLC
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Nephrostomy Devices Market Variables, Trends, & Scope
Chapter 4. Nephrostomy Devices Market: Product Estimates & Trend Analysis
Chapter 5. Nephrostomy Devices Market: End Use Estimates & Trend Analysis
Chapter 6. Nephrostomy Devices Market: Regional Estimates & Trend Analysis
Chapter 7. Competitive Landscape
Companies Mentioned
The leading players in the Nephrostomy Devices market include:- Boston Scientific Corporation
- Teleflex Incorporated.
- Cardinal Health.
- BD
- Cook Medical
- B. Braun Melsungen AG
- Coloplast Group
- Olympus Corporation
- Argon Medical Devices.
- UreSil LLC
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 100 |
| Published | September 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 1.36 Billion |
| Forecasted Market Value ( USD | $ 2.32 Billion |
| Compound Annual Growth Rate | 7.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
